Clinical Trial Update: Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Immuncell-LC for patients undergoing liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Immuncell-LC

Snippet

Sponsor: GC Cell Corporation | Conditions: Liver Transplantation | Phase 1, Phase 2 | Status: COMPLETED